{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:00:48Z","timestamp":1790802048453,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Older people usually present with adverse drug events (ADEs) with nonspecific symptoms such as cognitive decline, recurrent falls, reduced mobility, and\/or major deterioration. The aims of this study were to assess the ADEs of patients with dementia and presenting neuropsychiatric\/behavioral, and psychological symptoms in dementia (BPSD) and to categorize and identify the principal factors that allow to prevent ADEs, and separately ADEs that result in falls. To that end, a one-year prospective study in a psychogeriatric ward (July 2015 to July 2016) was performed. All patients admitted to this ward were eligible for enrolment. Patients who met any of the following criteria were excluded from the study: Patients without cognitive impairment, a length of stay under 7 days, and palliative or previous psychiatric pathology. We included 65 patients (60% women, 84.9 years \u00b1 6.7) with mild to moderate cognitive impairment, moderate to severe functional dependence, and a high prevalence of geriatric syndromes and comorbidity. A total of 87.7% were taking five or more drugs (mean 9.0 \u00b1 3.1). ADEs were identified during the interdisciplinary meeting and the follow up by clinical record. Sixty-eight ADEs (81.5% patients) were identified, of which 73.5% were not related to falls. From these, 80% were related to drugs of the nervous system. The Naranjo algorithm determined that 90% of ADEs were probable. The severity of the ADEs was Category E in 34 patients (68%). The number of preventable ADE according to the Schumork\u2013Thornton test was 58%. The main ADE was drowsiness\/somnolence (27.7%). ADEs related to falls represented a 26.5%. The balance between effective treatment and safety is complex in these patients. A medication review in interdisciplinary teams is an essential component to optimize safety prevention.<\/jats:p>","DOI":"10.3390\/ijerph16060934","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T04:06:55Z","timestamp":1552882015000},"page":"934","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Adverse Drug Events in Patients with Dementia and Neuropsychiatric\/Behavioral, and Psychological Symptoms, a One-Year Prospective Study"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6983-413X","authenticated-orcid":false,"given":"Marta H.","family":"Hern\u00e1ndez","sequence":"first","affiliation":[{"name":"Pharmacy Department, Grup Mutuam, 08024 Barcelona, Spain"},{"name":"School of Health Sciences Blanquerna, University Ramon Llull, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-3108","authenticated-orcid":false,"given":"Conxita","family":"Mestres","sequence":"additional","affiliation":[{"name":"School of Health Sciences Blanquerna, University Ramon Llull, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3193-6285","authenticated-orcid":false,"given":"Pilar","family":"Modamio","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacotherapy Unit, Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Junyent","sequence":"additional","affiliation":[{"name":"Mutuam G\u00fcell Hospital, 08024 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6279-5505","authenticated-orcid":false,"given":"Llu\u00eds","family":"Costa-Tutusaus","sequence":"additional","affiliation":[{"name":"School of Health Sciences Blanquerna, University Ramon Llull, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2983-1284","authenticated-orcid":false,"given":"Cecilia F.","family":"Lastra","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacotherapy Unit, Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4386-9315","authenticated-orcid":false,"given":"Eduardo L.","family":"Mari\u00f1o","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacotherapy Unit, Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/gerona\/61.5.511","article-title":"Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay","volume":"61","author":"Hanlon","year":"2006","journal-title":"J Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2125.2006.02831.x","article-title":"Is inappropriate medication use a major cause of adverse drug reactions in the elderly?","volume":"63","author":"Laroche","year":"2007","journal-title":"Br. J. Clin. Pharmacol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.2007.03064.x","article-title":"Incidence of fatal adverse drug reactions: A population-based study","volume":"65","author":"Wester","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00228-017-2225-3","article-title":"Hospital admissions due to adverse drug reactions in the ederly. A meta-analysis","volume":"73","author":"Oscanoa","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Prevalence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"ref_6","first-page":"2079","article-title":"A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting","volume":"9","author":"Alhawassi","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/jgs.14312","article-title":"Prevention of hospital-acquired adverse drug reactions in older people using screening tool of older persons\u2019 prescriptions and screening tool to alert to right treatment criteria: A cluster randomized controlled trial","volume":"64","author":"Gallagher","year":"2016","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Davies, E.C., Green, C.F., Taylor, S., Williamson, P.R., Mottram, D.R., and Pirmohamed, M. (2009). Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004439"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Patel, H., Bell, D., Molokhia, M., Srishanmuganathan, J., Patel, M., Car, J., and Majeed, A. (2007). Trends in hospital admissions for adverse drug reactions in England: Analysis of national hospital episode statistics 1998\u20132005. BMC Clin. Pharmacol., 7.","DOI":"10.1186\/1472-6904-7-9"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1345\/aph.10094","article-title":"Clinical and economic impact of adverse drug reactions in hospitalized patients","volume":"34","author":"Suh","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","article-title":"Which drugs cause preventable admissions to hospital? A systematic review","volume":"63","author":"Howard","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_12","unstructured":"(2018, July 16). Background Paper 7.3. Priority Medicines for Elderly. Available online: https:\/\/www.who.int\/medicines\/areas\/priority_medicines\/BP7_3Elderly.pdf."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00228-016-2170-6","article-title":"Hospitalizations due to preventable adverse reactions-a systematic review","volume":"73","author":"Patel","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.amjmed.2003.10.031","article-title":"Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly","volume":"116","author":"Schmader","year":"2004","journal-title":"Am. J. Med."},{"key":"ref_15","first-page":"307","article-title":"The cost of falls among the community-dwelling elderly","volume":"11","author":"Carroll","year":"2005","journal-title":"J. Manag. Care Pharm."},{"key":"ref_16","unstructured":"Centres for Disease Control and Prevention (2018, July 16). Home and Recreational Safety: Important Facts about Falls, Available online: http:\/\/www.cdc.gov\/homeandrecreationalsafety\/falls\/adultfalls.html."},{"key":"ref_17","first-page":"748","article-title":"Societal consequences of falls in the older population: Injuries, healthcare costs, and long-term reduced quality of life","volume":"71","author":"Hartholt","year":"2011","journal-title":"J. Trauma"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ageing\/afh028","article-title":"Consequences of falling in older men and women and risk factors for health service use and functional decline","volume":"33","author":"Stel","year":"2003","journal-title":"Age Ageing"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1999.tb01898.x","article-title":"Drugs and falls in older people: A systematic review and meta-analysis: I. Psychotropic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/gerona\/62.10.1172","article-title":"Medication as a risk factor for falls: Critical systematic review","volume":"62","author":"Hartikainen","year":"2007","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00228-015-1955-3","article-title":"Medications associated with falls in older people: Systematic review of publications from a recent 5-year period","volume":"71","author":"Park","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0898264310381277","article-title":"Psychotropic drugs and falls in the elderly people: Updated literature review and meta-analysis","volume":"23","author":"Bloch","year":"2011","journal-title":"J. Aging Health"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"371.e11","DOI":"10.1016\/j.jamda.2017.12.098","article-title":"Fall-Risk-Increasing Drugs: A systematic Review and Meta-Analysis: II. Psychotropics","volume":"19","author":"Seppala","year":"2018","journal-title":"J. Am. Med. Direct. Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"371.e1","DOI":"10.1016\/j.jamda.2017.12.013","article-title":"Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: I. Cardiovascular Drugs","volume":"19","author":"Seppala","year":"2018","journal-title":"J. Am. Med. Direct. Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1532-5415.1999.tb01899.x","article-title":"Drugs and falls in older people: A systematic review and meta-analysis: II. Cardiac and analgesic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"Altman","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/09638288809164103","article-title":"The Barthel ADL Index: A reliability study","volume":"10","author":"Collin","year":"1988","journal-title":"Int. Disabil. Stud."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Phychiatry."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1130-6343(08)72808-3","article-title":"Actualizaci\u00f3n de la clasificaci\u00f3n de errores de medicaci\u00f3n del grupo Ruiz-Jarabo 2000","volume":"32","year":"2008","journal-title":"Farmacia Hospitalaria"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharacol. Ther."},{"key":"ref_32","first-page":"538","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock","year":"1992","journal-title":"Hosp. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9343(86)90717-5","article-title":"Fall Risk Index for elderly patients based on number of chronic disabilities","volume":"80","author":"Tinetti","year":"1986","journal-title":"Am. J. Med."},{"key":"ref_34","unstructured":"Downton, J.H. (1993). Falls in the Elderly, Edward Arnold."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A drug burden index to define the functional burden of medications in older people","volume":"167","author":"Hilmer","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.archger.2015.10.002","article-title":"Systematic review on the use of anticholinergic scales in poly pathological patients","volume":"62","year":"2016","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_37","unstructured":"Griffin, F.A., and Resar, R.K. (2009). IHI Global Trigger Tool for Measuring Adverse Events, Institute for Healthcare Improvement. [2nd ed.]. Available online: http:\/\/www.ihi.org\/resources\/Pages\/IHIWhitePapers\/IHIGlobalTriggerToolWhitePaper.aspx."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Hernandez, M.H., Mestres, C., Junyent, J., Costa-Tutusaus, L., Modamio, P., Fernandez, C., and Mari\u00f1o, E.L. (2018). Effects of a multifaceted intervention in psychogeriatric patients: One-year prospective study. Eur. J. Hosp. Pharm.","DOI":"10.1136\/ejhpharm-2018-001647"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s40266-014-0206-0","article-title":"Adverse drug reactions in elderly subjects hospitalized in a specialized dementia management unit","volume":"31","author":"Kanagaratnam","year":"2014","journal-title":"Drug Aging"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/01.STR.27.10.1821","article-title":"Using the Downton Index to predict those prone to falls in stroke rehabilitation","volume":"27","author":"Nyberg","year":"1996","journal-title":"Stroke"},{"key":"ref_41","first-page":"11","article-title":"Anticholinergic effects of medication in elderly patients","volume":"62","author":"Tune","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"ref_42","unstructured":"(2017). Documento de la Sociedad de Psicogeriatria (SEPG) sobre el uso de antipsic\u00f3ticos en personas de edad avanzada. Psicogeritatria, 7, S1\u2013S37."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S104161020800803X","article-title":"Reduction of suboptimal prescribing and clinical outcome for dementia patients in a senior behavioural health inpatient unit","volume":"21","author":"Chan","year":"2009","journal-title":"Int. Psychogeriatr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40266-015-0296-3","article-title":"Tolerability of antihypertensive medications in older adults","volume":"32","author":"Dharmarajan","year":"2015","journal-title":"Drugs Aging"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/16\/6\/934\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:39:02Z","timestamp":1760186342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/16\/6\/934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["ijerph16060934"],"URL":"https:\/\/doi.org\/10.3390\/ijerph16060934","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]}}}